The Critical Side Effect Doctors Aren't Discussing: Out-of-Pocket Costs
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
Such a no-brainer: If patients who receive care at Hospital A are more likely to get readmitted to the hospital 10, 20 or 30 days after discharge than patients in Hospital B, then Hospital A must be doing something wrong. Perhaps clinicians at that hospital are less adept at diagnosing and managing patients’ problems. Perhaps…
There has been lots of talk lately about a slowdown in health care expenditures. This has caused even more debate about whether the slowdown is temporary or permanent, and whether the Affordable Care Act deserves any credit for it. Below here is a picture from a recent analysis in Health Affairs, which shows the change…
Healthcare is often really costly. And with increasing frequency, a significant chunk of those costs is being passed on to patients in the form of high deductibles, copays, or other out-of-pocket expenses. As a result, millions of Americans struggle to pay medical bills each year. What’s a poor patient to do? For starters–they can talk…
Two problems loom large over the American medical care system. First, we spend outrageous amounts of money on healthcare, with too many patients receiving too many services at too high a price. Second, our malpractice system is an international embarrassment, with too many healthcare providers sued by too many patients for too little reason. Many…
Ten years ago, my tennis partner suffered a stroke. He was a sixty-year-old at the time, working to move up into the top ten players in his age group. In the country! You could not have found a healthier sixty-year-old. He played tennis three-plus hours a day, scampering across the court like a hyperactive adolescent. …
Biologic drugs are a big deal for the pharmaceutical industry right now. Blockbuster chemicals for common conditions like diabetes and hypertension are largely things of the past. We’re getting pretty good at controlling those conditions, and few people expect a slew of major scientific breakthroughs that will lead to many more multibillion dollar treatments for…